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Genomics tools (gene- and protein-expressionstudies) can be used to find possible target
genes involved in a quantifiable trait or disease
state. However in many instances, cells and tissues
directly involved in the trait’s expression, for
example, brain tissue, are not amenable for gene
expression analysis. Whole blood cells share a mole-
cular make-up for cellular communication and gene
regulation systems with many other cell types, for
example, neuronal cells, and have the advantage of
being very accessible for gene profiling. We investi-
gated the feasibility of nationwide blood sample
collection for lymphocyte RNA isolation and real-
time PCR analysis to quantify genomic responses.
We tested several designs for blood collection and
storage: blood sampling in PAXgene blood collection
tubes and storage at –20°C, blood sampling in
heparin tubes and decanting the samples (with or
without in-vitro stimulus) into either PAXgene blood
collection tubes and storage at –20°C, or polypropy-
lene tubes followed by snap-freezing and storage at
–80°C. The latter procedure is the best cost-wise
when only small amounts of total RNA are needed
for downstream applications. Lymphocyte gene
expression studies are most likely hampered by the
quality of isolated RNA rather than the sampling
method. We show that large-scale nationwide
sample collections did not alter RNA quality or gene
expression levels when compared to sampling and
processing in a more controlled way. To this end, we
present an optimized protocol for easy and standard-
ized isolation of high quality RNA using the PAXgene
isolation kit. Based on these results, we suggest
that whole blood genomic data can be used as a
genomic probe in experimental and clinical research.
Gene expression is controlled by a constellation of so-
called transcription factors that are part of a genetic
network. The expression of genes in turn is determined
by genetic make-up, that is, by individual-specific
sequences in the regulatory elements of these genes,
and by the cellular environment that influences tran-
scription. Gene expression therefore carries both
valuable information on the individual’s genome, as
well as on the individual’s genome–environment inter-
action. Assessing genome expression in the human
context, however, is often unrealistic since biopsies of
certain tissues from living patients cannot be obtained.
To this end, blood lymphocytes have been proposed as
a convenient and accessible alternative (Gladkevich et
al., 2004). Blood cells share a molecular make-up for
cellular communication and basic gene regulation
systems with other types of cells in the body (Blalock,
1994). In principle, blood cells carry information on a
subset of the genetic network relating to the genes
expressed in these cells. As such they might pinpoint
genes of which the control is affected by mutation (e.g.,
polymorphisms). In addition, blood cells form biosen-
sors of which the gene expression is influenced by the
surrounding body fluid and all molecules therein. As
such, gene expression of blood cells might reveal previ-
ous or developing disease states and thus present
valuable diagnostic markers of an individual.
In addition, blood cells have the advantage that
various stimuli, or challenges, can easily be applied to
elicit genomic responses that may teach us more
about deficiencies in the underlying genetic network.
Indeed, studies on blood lymphocytes have revealed a
close association between the state of the immune
system and major psychiatric disorders (Coplan et al.,
1999; Schwarz et al., 2001; Stastny et al., 2003). In
this study, whole blood samples were stimulated with
dexamethasone as glucocorticoids have pronounced
effects on the metabolism, differentiation, prolifera-
tion, and cell survival of both the peripheral and
central systems (Alarid et al., 2003; Bianchi et al.,
2000; Rowland et al., 1998; Tonko et al., 2001).
Gene expression studies on stimulated whole
blood samples might include large-scale open
(microarray) or medium-scale targeted (real-time
PCR) screenings. Microarrays are a high-throughput
system where the expression of thousands of genes
can be analyzed at the same time, whereas real-time
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PCR is more labor-intensive. Real-time PCR is much
more sensitive both to low abundant RNA species (tran-
scription factors, receptors, transporters) as well as to
subtle changes in gene expression (Spijker et al., 2004).
Microarrays have previously been applied to study gene
expression changes in whole blood samples resulting
from various types of stimuli (Spijker et al., unpublished
results). In this study, a limited number of genes were
selected and real-time PCR used to quantify the genomic
responses. In addition, the feasibility of nationwide
blood sample collection of mothers of dizygotic twins
(MODZT) for which the blood samples were challenged
with dexamethasone during transport was tested by
comparing it to blood samples from local controls (col-
leagues) that were sampled and processed in a more
controlled way. From these samples, the quantity and
integrity of isolated RNA was checked, and gene expres-
sion measured under basal and dexamethasone-induced
conditions. Moreover, different blood collection and
storage procedures were compared.
Materials and Methods
Sample Collection
For testing different procedures of blood collection and
storage (Table 1), serial venous blood samples (maxi-
mally four 9 ml tubes within 4 minutes) were taken
from 11 healthy female donors (controls) after
informed consent using safety-lock butterfly needles.
An in-vitro stimulus was applied to some of these
samples (see below). Blood from only six of the female
donors (average age 31.8 ± 6.0), who were sampled at
the same time (all samples within a period of 10
minutes), was used for measuring gene expression, and
one donor was sampled twice with a 6-month delay.
Blood was drawn between 11:00 a.m. and 1:00 p.m.
For the six controls used for gene expression measure-
ments, blood was drawn between 12:30 p.m. and 1:00
p.m. Blood was collected either directly into PAX
blood collection tubes and stored for a maximum of 2
months at –20°C (PAX direct, Table 1), or it was col-
lected into heparin-coated tubes (Greiner) and (with or
without various in-vitro challenges) decanted into
either PAX blood collection tubes and stored for a
maximum of 2 months at –20°C (frozen in PAX; Table
1), or polypropylene tubes after which the samples
were snap-frozen on a mixture of dry ice and ethanol
(frozen before PAX; Table 1). For the latter procedure,
blood was thawed into PAX blood collection tubes
after which it followed the standard procedure of RNA
isolation (described below). All blood collection tubes
were inverted at least eight times immediately after col-
lection and before the next processing step.
Serial venous whole blood samples from three
mothers of dizygotic twins (MODZT) donors (see
Hoekstra et al., 2004) were obtained after informed
consent using safety-lock butterfly needles (within 6
minutes). Sampling took place during a two-month
period, with blood drawn between 7:00 a.m. and
10:00 a.m. Two additional EDTA tubes were drawn
before blood sampling for RNA isolation (see
Hoekstra et al., 2004). Samples were collected after
overnight fasting in two 9 ml lithium/sodium heparin
coated tubes (Greiner), and were decanted (with or
without in-vitro challenges) into polypropylene
(storage) tubes, after which they were snap-frozen (see
below). All blood collection tubes were inverted at
least eight times immediately after collection and
before the next processing step. 
Challenge Application and Storage
Before proceeding to the next step, (either direct freezing
or application of a stimulus; see below), all samples
were transferred and/or kept at room temperature. For
MODZT samples, proceeding to the next step took for
the most part between 10 and 30 minutes after sampling
(but no longer than one hour). For control samples, this
was within 20 minutes after sampling. Whole blood
samples (MODZT and controls) collected in one of the
heparin tubes from each participant were divided into
three ~3 ml portions in 4 ml polypropylene tubes
(Greiner). These aliquots were snap-frozen, and stored
at –80°C until further processing. A challenge was
applied to the second heparin tube by stimulation with
10–7 M Dexamethasone (Dex; Sigma). For controls, a
third (E. coli LPS, [Sigma] 10 ng/ml blood) and fourth
(10–7 M Dexamethasone and E. coli LPS, 10 ng/ml
blood) heparin tube were stimulated as well. All stimu-
lated samples were incubated at 37°C. For controls,
samples were rotated in a room of constant tempera-
ture, and for MODZT, the challenge was induced
during transport and continued after arrival at the
Leiden laboratory for no longer than 6 hours (variations
of 30 minutes). The latter samples lay flat in the insu-
lated box of constant temperature (37°C) and were
mixed by the motion of the transporting vehicle. After
all stimulations, sample tubes were inverted at least
eight times and subsequently divided in three ~3 ml
aliquots, snap frozen and stored at –80°C. 
RNA Isolation
After storage of the MODZT and control samples at
–80°C, the tubes containing the ~3 ml aliquots of whole
blood were thawed in PAX (PreAnalytiX; Qiagen) gene
Table1
Comparison of RNA Yield
(Standardized from 2.5 ml Blood) Using Different Procedures 
Average yield (µg/µl ) ± SD n
PAX direct 5.8 ± 1.3 7
Frozen in PAX 8.7 ± 2.0 24
Frozen before PAX 3.7 ± 1.7 60
Note: Blood can be drawn immediately into the PAXgene collection tube (PAX direct),
or can be drawn into heparin-coated tubes, whereafter the blood sample
is either directly transferred to the PAX tube (frozen in PAX), or it followed
the procedure as described in this paper (frozen before PAX).
n indicates the number of isolations on which this observation was based.
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blood collection tubes (added volume of 2.5 ml blood;
maximum capacity of the PAX tubes), inverted at least
10 times and incubated at room temperature for at least
3 hours. PAX gene blood collection tubes with blood
samples (PAX direct and frozen in PAX; Table 1) stored
at –20°C were thawed at room temperature for at least
2 hours, and were inverted at least three times before
further processing. Total RNA was extracted according
to the manufacturer’s protocol (Qiagen) with several
important adjustments. To ensure full separation and
subsequent removal of all protein debris, 325 µl BR2
binding buffer (instead of 300 µl) was added to the BR1
buffer prior to proteinase K-treatment, and after 10
minutes of incubation at 50°C and 1 minute of centrifu-
gation at 14,000 rpm, debris was removed by sucking
the debris into a 1 ml tip while the supernatant was kept
for further processing. To ensure complete genomic
DNA removal for the downstream real-time PCR appli-
cation, an on-column DNase digestion was performed
with the Qiagen RNase-free DNase set (Qiagen).
Furthermore, a total of 90 µl BR5 elution buffer (twice
45 µl) was used to elute the sample from the column. 
The quantity and integrity of the extracted RNA
was measured using the nano-assay on the Agilent
2100 Biosizing (Agilent Technologies). In addition,
quantity of extracted RNA was determined using
spectrophotometry (NanoDrop ND–1000 UV-Vis
Spectrophotometer, Nanodrop Technologies). Typical
RNA yields after storage at –80°C is 2–4 µg per PAX
isolation, whereas this was 4–6 µg when whole blood
samples were processed directly into PAX-tubes after
heparin collection or DEX-challenge. RNA samples
were then stored at –80°C until further processing. 
Reverse Transcription
For downstream real-time PCR analysis, 500 ng of
total RNA was reverse transcribed using random
primers (25 pmol), RNA-guard (15 U, Promega) and
MMLV reverse transcriptase (20 U; Roche) according
to the manufacturer’s protocol in a volume of 25 µl for
1 hour at 37°C. Following synthesis, samples were pre-
cipitated by addition of 3 volumes of 100% ethanol
and 0.1 volume of NaAc (3 M, pH 5.6), incubation on
ice for 30 minutes and centrifugation for 30 minutes at
14,000 rpm at 4°C. The supernatants were discarded
and pellets were washed by addition of 500 µl 70%
ethanol and centrifugation for 5 minutes at 14,000
rpm at 4°C. The supernatants were then thoroughly
removed, and the pellets air-dried (approximately 10
minutes at 37°C). Then, pellets were resuspended in 25
µl distilled water and samples were stored at 4°C.
Real-Time Quantitative Polymerase Chain
Reaction (qPCR) 
For measuring relative expression levels, PCR reactions
(10 µl; ABI PRISM 7900) were performed with tran-
script-specific primers (600 nM) on cDNA
corresponding to ~2 ng RNA, using cycle-settings: 10
minutes 50°C, 40 cycles of 95°C for 20 seconds, 60°C
for 1 minute, followed by a dissociation from 60°C to
95°C in 15 minutes. Criteria for and design of primers
as well as calculations were as described previously
(Jacobs et al., 2002). In short, three potential reference
genes (encoding hypoxanthine phosphoribosyl trans-
ferase [HPRT], glyceraldehyde 3-dehydrogenase
[GAPDH] and β-actin) were measured first for stable
relative expression across all individual samples. From
this, two genes (encoding GAPDH and β-actin) were
selected as reference genes. Then for each gene (encod-
ing DAF, DUSP6, NFKBIA, TNFAIP3, RGS2, TOB1
and VDUP) the cycle of threshold (Ct) values were
used to calculate the relative level of gene expression
normalized to the mean of the two reference controls
in each sample (HEP, expression in the heparin sample;
DEX, expression in the Dex-stimulated sample) which
will be denoted by Ctnorm. For each sample, the Dex-
induced expression, indicated as the Dex-induced ratio
(log2-scale) for gene x, rx, was calculated from the nor-
malized values as
rx = (Ctnormx, HEP – Ctnormx, DEX)
and average regulation values were calculated from
these individual ratios. 
Results and Discussion
RNA Yield and Purification
Integrity of RNA samples is essential for any down-
stream application, for example, real-time PCR or
microarrays. Isolation of RNA from whole blood
samples using the PAX system yielded high quality
RNA where both ribosomal bands were visible (28S
more abundant than 18S, Figure 1). There was no dif-
ference in RNA quantity or quality for heparin or
Dex-stimulated samples. However, a difference in
RNA quantity was observed after freezing samples.
There was a ~30% reduction in RNA yield when
compared to blood sampling directly into PAX tubes,
as suggested by the manufacturer. Despite this reduc-
tion, freezing whole blood samples prior to adding
them to the PAX-buffer is a good alternative for large
longitudinal studies where gene expression analysis
needs little RNA (real-time PCR or microarrays with
amplified RNA). The highest RNA yield was obtained
when blood was first drawn into heparin tubes, trans-
ferred to the PAX tube (Table 1) and frozen at –20°C.
There were no differences between yields for individu-
als, nor for the stimulus applied (ANOVA). As an
additional control, gene expression was measured
from blood samples of one control sampled twice in a
period of 6 months.
A critical step in the RNA isolation procedure
using the PAX-system is the removal of proteins from
the sample prior to loading it onto the RNA isolation
column. After addition of buffer BR2 (typically add
325 µl) and the proteinase K-treatment, proteins
should aggregate and be removed from the sample. If
this aggregate does not form, additional buffer BR2
should be added.
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Many gene expression studies of blood samples
involve isolation of a particular cell population from
whole blood. Unpublished studies in our laboratory
showed a dramatic change in basal gene expression of
whole blood sample after centrifugation. To this end,
using only whole blood samples in combination with
the PAX-isolation method for RNA is suggested when
looking at basal gene expression.
Gene Expression in Peripheral Blood Samples
Previously we performed microarray experiments with
RNA extracted from whole blood samples stimulated
with Dex or without stimulation (unpublished results).
Based on these experiments, several genes were selected
that were abundantly expressed in peripheral blood
cells and/or were regulated by Dex. These were used
for a SYBR Green dye-based real-time PCR analysis.
There are two house-keeping genes among these that
served as internal reference for normalization of input-
RNA. Our real-time PCR used two conventional
primers to amplify cDNA and the SYBR Green I dye, a
highly specific double-stranded DNA binding dye, for
detection of formed product during PCR. In addition,
this assay has the advantage of being highly sensitive
and allows post-hoc analysis of the specificity of the
formed PCR product.
Firstly, the expression level of several potential ref-
erence genes (β-actin, HPRT and GAPDH) was
measured across all individual samples for stable rela-
tive expression (Garcia-Vallejo et al., 2004). This has
to be established for each cell-type used as (1) the
mRNA levels of the target genes are expressed in a
relative way to the reference genes, and (2) it is
known that some of the potential reference genes are
differentially expressed due to cell-type or cell-treat-
ment (Hamalainen et al., 2001). As a measurement
for this, the SD was calculated on the relative expres-
sion of each set of two potential reference genes in
each sample. The lowest SD was obtained for the
GAPDH/β-actin combination. We observed an SD of
0.46, which is reasonably stable when compared to
the SD values obtained from brain tissue of individual
isogenic laboratory animals (~0.18). 
Gene expression for all heparin samples was ana-
lyzed to verify the quality of cDNA (Figure 2). Gene
expression for all transcripts in MODZT donors (n = 3)
was very similar to that obtained from controls (n = 6).
A reason for the low variation observed in basal expres-
sion levels (Whitney et al., 2003) could be that gene
expression was measured with real-time PCR. However,
a striking difference was observed for the expression of
RGS-2: RGS-2 has reduced expression in all MODZT
donors (p < .005; t test; Figure 2A, B). Although subtle
differences in sample processing could explain this dif-
ference in basal expression level (albeit that other genes
are not affected by this), it may be also be caused by
other factors such as genetic predisposition and limited
sample size. Future study will shed more light on this.
Figure 1
Integrity of total RNA from whole blood samples before and after DEX
stimulation.
Electropherograms (and gel-like images, inset) are shown for RNA isola-
tions from two MODZT donors (68023–1095, A; 68021–1086, B) and a
control donor (c15, C). The ribosomal RNAs (18S and 28S, 46–48 minutes
and 52–58 minutes, respectively) can be distinguished as two sharp
peaks with ratios 28S/18S approaching 2, in addition to the marker peak
(25 minutes), which allows for sample alignment. There was no difference
in RNA quality due to the Dex-stimulation (compare electropherograms of
heparin samples [samples ‘A’ in panels A and B and ‘HEP’ in panel C] to
those after Dex-stimulation [samples ‘B’ in panels A and B; ‘DEX’ in panel
C]. RNA isolation of whole blood drawn into a PAX-tube directly (C,
‘direct’, thin black line; y-axis on the right) showed that freezing/thawing
whole blood samples prior to addition of the PAX isolation buffer had no
effect on the quality of isolated RNA, but only had an effect on the quan-
tity of isolated RNA. Note the absence of a 5S ribosomal peak in all
electropherograms due to silica-column isolation.
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Next, Dex-induced regulation was analyzed in
MODZT samples (n = 2), and controls (n = 6) for a
selected set of genes. Expression of several genes is
known to be affected by Dex-stimulation in various
cell types, that is, NFKBIA (Alcorn et al., 2004;
Chauhan et al., 2002; Medh et al., 2003), TNFAIP3
(Galon et al., 2002), RGS2 (Homme et al., 2003), and
VDUP (Medh et al., 2003). All selected genes were sig-
nificantly induced (Student’s t test; p < .01) upon
Dex-stimulation (Figure 2C) in the control samples. It
must be noted that increased power was obtained from
the paired type of analysis that was performed, that is,
normalizing the Dex-induced expression to the
heparin-sample of the same individual. MODZT
donors showed a similar Dex-induced change in
expression for all genes compared with controls.
Slightly increased (NFKB1) and decreased (RGS2)
expression was observed in the MODZT samples. 
Figure 2
Gene expression in whole blood samples using qPCR.
Gene expression was measured for several genes abundantly expressed in whole blood samples. A) Relative expression level (normalized to the
average of the control genes) of several genes (DAF: complement decay-accelerating factor/CD55; DUSP6: dual specificity protein phosphatase
6/MKP3; TNFAIP3: tumor necrosis factor, alpha-induced protein 3; NFKBIA: NF-kappaB inhibitor alpha/MAD3; RGS-2: regulator of G-protein
signaling 2; NFKB1: Nuclear factor NF-kappa-B p105 subunit; TOB1: Transducer of erbB-2 1; VDUP1: 1,25-dihydroxyvitamin D-3 upregulated
protein1/TXNIP) is presented in arbitrary units (log2-scale) for the average of the control samples (controls, black), and for three individual MODZT
donors (white, light gray, dark gray, see legend box). A & B) All genes, except for RGS-2, showed a similar level of expression in the MODZT
donors compared with the controls. RGS-2 showed a significant lower expression (p < .005; Student’s t test). C) Dex-induced regulation was
measured for a selection of genes, and is presented as fold-regulation (to heparin; log2-scale) for the average of the control samples, and for two
individual MODZT donors. For all genes, the Dex-induced regulation was significant (p < .01; Student’s t test) Dex-treatment resulted in similar
activation of genes. In the MODZT samples, RGS-2 and TNFKB1 show slightly more repression and induction respectively. D) Dex-, LPS- or
Dex+LPS-induced regulations for several genes of samples (a and b) taken from one control (c15) within a 6 month timeframe were compared
to each other. The line indicates the correlation, the R 2 value is indicated.
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Every individual sample was then correlated for
all the gene expression values. The averaged correla-
tions of Dex-induced regulations among controls
were very similar to the averaged correlations
between MODZT and controls (R2 is .76 and .72,
respectively). Based on this, we concluded that
although sampling of blood and incubation with the
stimulus (Dex) was slightly different for MODZT and
controls, small variations in sampling protocols — as
is inevitable when sampling from humans or when
comparing different studies — could be ignored.
The induced gene expression levels of one control,
who was sampled twice within a 6-month timeframe,
was compared to analyze the stability of gene expres-
sion over time (Figure 2D). The correlation (R2 is .74)
was similar to the averaged correlation value obtained
within individuals. In addition to the observation that
the RNA quality was good for both samples, the small
variation in expression levels for this subject is most
likely due to time of blood collection. More observa-
tions are needed to exclude any seasonal effect.
Conclusion
It was shown that nationwide blood sampling is feasi-
ble in terms of quality of RNA for downstream
genomic applications. There is minimal variation
between samples when our blood sampling and pro-
cessing (stimulus incubation, freezing samples prior to
RNA isolation) is used. This shows that there are little
caveats in the collection procedure in terms of feasibil-
ity (transport, etc.) or quality of RNA. This is
important because it is inevitable that variation in a
collection procedure will exist, even within one study.
In particular, our procedure of blood collection and
storage (freezing before isolation) is a good alternative
for large longitudinal studies where only a limited
number of samples will finally be analyzed, as a result
of the reduction in chemical and storage capacity costs
as well as increased processing efficiency.
Variation in samples as apparent in gene expres-
sion studies (apart from biological source variation)
could most likely be attributed to the quality of the
RNA. It was shown that high quality RNA can be
obtained using a simple, easy, and, above all, stan-
dardized RNA isolation protocol, which results in
reproducible gene expression measurements.
Therefore, gene expression analysis on stimulated
peripheral blood cells is a feasible tool to screen for
biomarkers for a particular trait. 
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